These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3442977)

  • 1. Malignant immunoblastic lymphoma complicated by IgM gammopathy and digoxin-like immunoreactive substance.
    Ng JP; Green ST; McGovern E; Horn EM; Whiting B; Cumming RL; Hogg RB
    Clin Lab Haematol; 1987; 9(4):421-3. PubMed ID: 3442977
    [No Abstract]   [Full Text] [Related]  

  • 2. IgE-IgM kappa gammopathy associated with lymphocytic lymphoma: immunological evaluation.
    Brown GL; Corby DG; Lima JE; DiBella NJ; Nelson JK; Gray MR
    Mil Med; 1977 Dec; 142(12):921-5. PubMed ID: 414155
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of lymphocytic lymphoma (B cell type) with monoclonal gammopathy (IgM, lambda type) (author's transl)].
    Nakajima H; Uchiyama M; Ikezawa Z
    Nihon Hifuka Gakkai Zasshi; 1977 Jun; 87(7):443-5. PubMed ID: 409866
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
    Dasgupta A; Nakamura A; Doria L; Dennen D
    Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary lymphoma of the lung with monocional gammopathy IgM of kappa - type. Case study and review of the literature (author's transl)].
    Debeljak A; Ferluga D
    Plucne Bolesti Tuberk; 1981; 33(4):223-37. PubMed ID: 6808533
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 7. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum IgA-lambda monoclonal gammopathy in a patient with immunoblastic sarcoma with IgM-kappa cell surface immunoglobulin].
    Urbano Ispizua A; Estruch Riba R; Anegón I; Gallart T; Bladé J; Urbano-Márquez A; Rozman C
    Med Clin (Barc); 1985 Mar; 84(10):405-7. PubMed ID: 3921785
    [No Abstract]   [Full Text] [Related]  

  • 10. Digoxin-like immunoreactive substance in renal failure.
    Seyrek N; Paydas S; Sargin O; Günday V; Sağliker Y
    Nephron; 1994; 67(2):253-4. PubMed ID: 8072625
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substances in kidney- and liver-transplant patients.
    Dasgupta A; Dennen DA; Saldana S; Chou H; McLawhon RW
    Clin Chem; 1990 Jan; 36(1):171-2. PubMed ID: 2297924
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin immunoassays in normotensive third trimester pregnancy.
    Phelps S; Hammond K; Bottorff M; Sibai B
    Ther Drug Monit; 1987 Dec; 9(4):489. PubMed ID: 3424417
    [No Abstract]   [Full Text] [Related]  

  • 17. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 19. Digoxin-like immunoreactive substance levels in cord blood obtained from twins.
    Morris RG; Frewin DB; Saccoia NC; McPhee AJ; Goldsworthy WL
    Eur J Clin Pharmacol; 1991; 40(2):199-200. PubMed ID: 2065703
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in sera from umbilical cord, infants and mothers.
    Chen MR; Wu WH; Sung TC; Chen PN; Wang EY; Yang YC
    Taiwan Yi Xue Hui Za Zhi; 1987 Sep; 86(9):952-6. PubMed ID: 3694167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.